Suzanne Leta Benedict
Veterinary in San Diego, CA
License number
Massachusetts 382
Issued Date
Jul 28, 2015
Type
Veterinarian Tufts Practitioner
Address
Address
San Diego, CA 92115
Personal information
See more information about Suzanne Leta Benedict at radaris.comName
Address
Phone
4099 Sunnyhill Dr, Carlsbad, CA 92008
12751 Mariposa Rd SPC 1, Victorville, CA 92395
11628 Inwood Dr, Riverside, CA 92503
4099 Sunnyhill Dr, Carlsbad, CA 92008
Professional information
See more information about Suzanne Leta Benedict at trustoria.com
Suzanne Benedict - San Diego, CA
Suzanne Benedict - San Diego, CA
Work:
Veterinary Specialty Hospital of San Diego
Rotating Intern Western University of Health Sciences
Mentor/PI Western University of Health Sciences - Pomona, CA
Tutor VCA Emergency Animal Hospital and Referral Center - San Diego, CA
Veterinary Assistant/Technician Student Government Association - Pomona, CA
Treasurer of DVM class of 2012 SeaWorld - San Diego, CA
Educator/Camp Counselor San Diego State University Pre-Vet Club - San Diego, CA
Vice President Countryside Veterinary Clinic - Wenatchee, WA
Kennel Staff Wenatchee Valley College
Mentor/PI Chelan-Douglas County
4-H State Ambassador
Rotating Intern Western University of Health Sciences
Mentor/PI Western University of Health Sciences - Pomona, CA
Tutor VCA Emergency Animal Hospital and Referral Center - San Diego, CA
Veterinary Assistant/Technician Student Government Association - Pomona, CA
Treasurer of DVM class of 2012 SeaWorld - San Diego, CA
Educator/Camp Counselor San Diego State University Pre-Vet Club - San Diego, CA
Vice President Countryside Veterinary Clinic - Wenatchee, WA
Kennel Staff Wenatchee Valley College
Mentor/PI Chelan-Douglas County
4-H State Ambassador
Thiazole Compounds And Pharmaceutical Compositions For Inhibiting Protein Kinases And Methods For Their Use
Thiazole Compounds And Pharmaceutical Compositions For Inhibiting Protein Kinases And Methods For Their Use
US Patent:
2002002, Feb 28, 2002
Filed:
Feb 15, 2001
Appl. No.:
09/783584
Inventors:
Shao Chu - Encinitas CA, US
Larry Alegria - San Diego CA, US
Steven Bender - Oceanside CA, US
Suzanne Benedict - San Diego CA, US
Allen Borchardt - San Diego CA, US
Robert Kania - San Diego CA, US
Mitchell Nambu - San Diego CA, US
Sepehr Sarshar - Cardiff By The Sea CA, US
Dilip Bhumralkar - San Diego CA, US
Zhengwei Peng - San Diego CA, US
Michelle Yang - San Diego CA, US
Larry Alegria - San Diego CA, US
Steven Bender - Oceanside CA, US
Suzanne Benedict - San Diego CA, US
Allen Borchardt - San Diego CA, US
Robert Kania - San Diego CA, US
Mitchell Nambu - San Diego CA, US
Sepehr Sarshar - Cardiff By The Sea CA, US
Dilip Bhumralkar - San Diego CA, US
Zhengwei Peng - San Diego CA, US
Michelle Yang - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc.
International Classification:
C07D419/02, A61K031/427
US Classification:
514/370000, 548/191000
Abstract:
Diaminothiazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.